Effect of 12 weeks of once-daily tiotropium/olodaterol on exercise endurance during constant work-rate cycling and endurance shuttle walking in chronic obstructive pulmonary disease | Zendy

François Maltais | Zendy; Denis E. O’Donnell | Zendy; Juan Bautista Gáldiz Iturri | Zendy; AnneMarie Kirsten | Zendy; Dave Singh | Zendy; Alan Hamilton | Zendy; Kay Tetzlaff | Zendy; Yihua Zhao | Zendy; Richard Casaburi | Zendy

Open Access

Effect of 12 weeks of once-daily tiotropium/olodaterol on exercise endurance during constant work-rate cycling and endurance shuttle walking in chronic obstructive pulmonary disease

Author(s) -

François Maltais,

Denis E. O’Donnell,

Juan Bautista Gáldiz Iturri,

AnneMarie Kirsten,

Dave Singh,

Alan Hamilton,

Kay Tetzlaff,

Yihua Zhao,

Richard Casaburi

Publication year - 2018

Publication title -

therapeutic advances in respiratory disease

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.022

H-Index - 37

eISSN - 1753-4666

pISSN - 1753-4658

DOI - 10.1177/1753465818755091

Subject(s) - medicine , placebo , copd , clinical endpoint , anesthesia , physical therapy , randomized controlled trial , alternative medicine , pathology

Tiotropium/olodaterol 5/5 µg improved endurance time during cycle ergometry versus placebo, with a strong tendency to also improve walking endurance time. [ ClinicalTrials.gov identifier: NCT01525615.].

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research